| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/29/2004 | EP1385874A4 Alpha conotoxin peptides with analgesic properties |
| 09/29/2004 | EP1303527B1 Matrix metalloproteinase inhibitors |
| 09/29/2004 | EP1299350B1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 09/29/2004 | EP1254143B1 Lipid-based drug delivery systems |
| 09/29/2004 | EP1210320B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1202959B1 Aminobenzophenones as inhibitors of il-1-beta and tnf-alpha |
| 09/29/2004 | EP1202957B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/29/2004 | EP1200400B1 Substituted pyrrolidin-2,3,4-trion derivatives useful as nmda-receptor antagonists |
| 09/29/2004 | EP1189881B1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 09/29/2004 | EP1181278B1 Cyclic amine derivatives and their uses |
| 09/29/2004 | EP1176960B1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 09/29/2004 | EP1169302B1 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
| 09/29/2004 | EP1153015B1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 09/29/2004 | EP1144412B1 Immunosuppressive effects of pteridine derivatives |
| 09/29/2004 | EP1123295B1 Bicyclic nitrogen heterocycles |
| 09/29/2004 | EP1100483B1 Glucocorticoid-selective anti-inflammatory agents |
| 09/29/2004 | EP1090019B1 Adenosine derivatives |
| 09/29/2004 | EP1059913B1 Emulsion preconcentrates containing cyclosporin or a macrolide |
| 09/29/2004 | EP1019040B1 Aryl ureas for the treatment of inflammatory or immunomodulatory diseases |
| 09/29/2004 | EP0736016B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor |
| 09/29/2004 | CN1533399A 免疫调节肽 Immunomodulatory peptides |
| 09/29/2004 | CN1533392A Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1531965A Medicinal wine for dredging channels, subduing swelling and stopping pain |
| 09/29/2004 | CN1531960A Gastrodia tuber rheumatism health wine |
| 09/29/2004 | CN1531959A Gastrodia tuber rheumatism pill |
| 09/29/2004 | CN1531950A Plaster medicine composition with multiple purpose for treating affection pain due to dampness |
| 09/29/2004 | CN1531936A Chinese medicine composition and preparation for treating pelvic inflammation of male and female and its preparing method |
| 09/29/2004 | CN1531925A Process for preparing colatemo solid preparation and its solid preparation |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168725C Formulation for protection against oxidative stress containing beozofuranone derivatives |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168693C Substituted phenols and thiophenols useful as antioxidant agents |
| 09/29/2004 | CN1168479C Ointment for curing rheumatism and osteoarthropathy |
| 09/29/2004 | CN1168474C Foot health keeping medicine |
| 09/29/2004 | CN1168454C Jusheng oil and preparation process |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797722 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 09/28/2004 | US6797708 Enzyme inhibitors such as 4-(2-(1-benzhydryl-2-(2-((benzyl-sulfonyl)amino)ethyl)-5-chloro-1h-indol-3 -yl)ethoxy) benzoic acid, used as analgesics or antiinflammatory agents |
| 09/28/2004 | US6797706 Heterocyclecarboxamide derivative |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797285 Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/23/2004 | WO2004081013A1 Protein kinase inhibitors |
| 09/23/2004 | WO2004080999A1 Pyrazole compounds useful in the treatment of inflammation |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080966A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 09/23/2004 | WO2004080956A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate hydrochloride crystalline salt |
| 09/23/2004 | WO2004080955A1 S-[2-[1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate crystalline salt |
| 09/23/2004 | WO2004080954A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate form ii crystalline salt |
| 09/23/2004 | WO2004080953A1 S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine salicylate monohydrate crystalline salt |
| 09/23/2004 | WO2004080951A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 09/23/2004 | WO2004080478A1 Therapeutic and prophylactic compositions and uses therefor |
| 09/23/2004 | WO2004080447A1 Titration dosing regimen for controlled release tramadol |
| 09/23/2004 | WO2004080385A2 Compositions and methods for diagnosing and treating an inflammation |
| 09/23/2004 | WO2004063185A8 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004038006A3 Purine nucleosides |
| 09/23/2004 | WO2003087815A3 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein |
| 09/23/2004 | WO2003043518A3 Methods and products for oral care |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186179 Pharmaceutical composition |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186114 Cytokine inhibitors |
| 09/23/2004 | US20040186111 Therapeutic agents useful for treating pain |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186072 Use of esters of long-chain fatty acids for treatment of autoimmune diseases |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma |
| 09/23/2004 | US20040185460 kits for drug screening by gel-shift assay, western blot, phage-based expression cloning, co-fractionation by chromatography, co-precipitation, cross linking, interaction trap/two hybrid analysis, and enzyme linked immunosorbent assay (ELISA) |